111 related articles for article (PubMed ID: 22426479)
21. Tumor suppressive microRNA-133a regulates novel molecular networks in lung squamous cell carcinoma.
Moriya Y; Nohata N; Kinoshita T; Mutallip M; Okamoto T; Yoshida S; Suzuki M; Yoshino I; Seki N
J Hum Genet; 2012 Jan; 57(1):38-45. PubMed ID: 22089643
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of serum miRNA-21 expression in human non-small cell lung cancer.
Wang ZX; Bian HB; Wang JR; Cheng ZX; Wang KM; De W
J Surg Oncol; 2011 Dec; 104(7):847-51. PubMed ID: 21721011
[TBL] [Abstract][Full Text] [Related]
23. Identification of direct targets for the miR-17-92 cluster by proteomic analysis.
Kanzaki H; Ito S; Hanafusa H; Jitsumori Y; Tamaru S; Shimizu K; Ouchida M
Proteomics; 2011 Sep; 11(17):3531-9. PubMed ID: 21751348
[TBL] [Abstract][Full Text] [Related]
24. Regulation of the epidermal growth factor receptor gene expression in a morphological variant isolated from an epidermal growth factor receptor-deficient small cell lung carcinoma cell line.
Gamou S; Shimosato Y; Shimizu N
Cell Growth Differ; 1990 Aug; 1(8):351-9. PubMed ID: 1980602
[TBL] [Abstract][Full Text] [Related]
25. MiR-512-5p induces apoptosis and inhibits glycolysis by targeting p21 in non-small cell lung cancer cells.
Chu K; Gao G; Yang X; Ren S; Li Y; Wu H; Huang Y; Zhou C
Int J Oncol; 2016 Feb; 48(2):577-86. PubMed ID: 26648284
[TBL] [Abstract][Full Text] [Related]
26. Downregulation of miR-16 promotes growth and motility by targeting HDGF in non-small cell lung cancer cells.
Ke Y; Zhao W; Xiong J; Cao R
FEBS Lett; 2013 Sep; 587(18):3153-7. PubMed ID: 23954293
[TBL] [Abstract][Full Text] [Related]
27. Aberrant epidermal growth factor receptor signaling and enhanced sensitivity to EGFR inhibitors in lung cancer.
Amann J; Kalyankrishna S; Massion PP; Ohm JE; Girard L; Shigematsu H; Peyton M; Juroske D; Huang Y; Stuart Salmon J; Kim YH; Pollack JR; Yanagisawa K; Gazdar A; Minna JD; Kurie JM; Carbone DP
Cancer Res; 2005 Jan; 65(1):226-35. PubMed ID: 15665299
[TBL] [Abstract][Full Text] [Related]
28. Effect of verapamil on the expression of EGFR and NM23 in A549 human lung cancer cells.
Zhang C; Lv F; Zhou L; Li X; Wu XX; Hoffman RM
Anticancer Res; 2009 Jan; 29(1):27-32. PubMed ID: 19331130
[TBL] [Abstract][Full Text] [Related]
29. MiR-181a-5p inhibits cell proliferation and migration by targeting Kras in non-small cell lung cancer A549 cells.
Ma Z; Qiu X; Wang D; Li Y; Zhang B; Yuan T; Wei J; Zhao B; Zhao X; Lou J; Jin Y; Jin Y
Acta Biochim Biophys Sin (Shanghai); 2015 Aug; 47(8):630-8. PubMed ID: 26124189
[TBL] [Abstract][Full Text] [Related]
30. Downregulation of miR-497 promotes tumor growth and angiogenesis by targeting HDGF in non-small cell lung cancer.
Zhao WY; Wang Y; An ZJ; Shi CG; Zhu GA; Wang B; Lu MY; Pan CK; Chen P
Biochem Biophys Res Commun; 2013 Jun; 435(3):466-71. PubMed ID: 23673296
[TBL] [Abstract][Full Text] [Related]
31. Deregulated expression of miR-106a predicts survival in human colon cancer patients.
Díaz R; Silva J; García JM; Lorenzo Y; García V; Peña C; Rodríguez R; Muñoz C; García F; Bonilla F; Domínguez G
Genes Chromosomes Cancer; 2008 Sep; 47(9):794-802. PubMed ID: 18521848
[TBL] [Abstract][Full Text] [Related]
32. Alterations of microRNAs in cisplatin-resistant human non-small cell lung cancer cells (A549/DDP).
Wang Q; Zhong M; Liu W; Li J; Huang J; Zheng L
Exp Lung Res; 2011 Sep; 37(7):427-34. PubMed ID: 21787234
[TBL] [Abstract][Full Text] [Related]
33. Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung.
Rusch V; Baselga J; Cordon-Cardo C; Orazem J; Zaman M; Hoda S; McIntosh J; Kurie J; Dmitrovsky E
Cancer Res; 1993 May; 53(10 Suppl):2379-85. PubMed ID: 7683573
[TBL] [Abstract][Full Text] [Related]
34. Paxillin predicts survival and relapse in non-small cell lung cancer by microRNA-218 targeting.
Wu DW; Cheng YW; Wang J; Chen CY; Lee H
Cancer Res; 2010 Dec; 70(24):10392-401. PubMed ID: 21159652
[TBL] [Abstract][Full Text] [Related]
35. miR-199a-5p and miR-495 target GRP78 within UPR pathway of lung cancer.
Ahmadi A; Khansarinejad B; Hosseinkhani S; Ghanei M; Mowla SJ
Gene; 2017 Jul; 620():15-22. PubMed ID: 28363780
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA regulation of growth factor receptor signaling in human cancer cells.
Giles KM; Barker A; Zhang PM; Epis MR; Leedman PJ
Methods Mol Biol; 2011; 676():147-63. PubMed ID: 20931396
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic Role of MiR-140-5p for the Treatment of Non-small Cell Lung Cancer.
Flamini V; Jiang WG; Cui Y
Anticancer Res; 2017 Aug; 37(8):4319-4327. PubMed ID: 28739724
[TBL] [Abstract][Full Text] [Related]
38. miR-34c may protect lung cancer cells from paclitaxel-induced apoptosis.
Catuogno S; Cerchia L; Romano G; Pognonec P; Condorelli G; de Franciscis V
Oncogene; 2013 Jan; 32(3):341-51. PubMed ID: 22370637
[TBL] [Abstract][Full Text] [Related]
39. Expression of miR-150 and miR-3940-5p is reduced in non-small cell lung carcinoma and correlates with clinicopathological features.
Sun Y; Su B; Zhang P; Xie H; Zheng H; Xu Y; Du Q; Zeng H; Zhou X; Chen C; Gao W
Oncol Rep; 2013 Feb; 29(2):704-12. PubMed ID: 23228962
[TBL] [Abstract][Full Text] [Related]
40. Integrative analysis of microRNA and mRNA expression profiles in non-small-cell lung cancer.
Yang C; Sun C; Liang X; Xie S; Huang J; Li D
Cancer Gene Ther; 2016 Apr; 23(4):90-7. PubMed ID: 26964645
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
